청리자감탕이 Streptozotocin으로 誘發된 흰쥐의 糖尿病 및 糖尿病合倂症에 미치는 영향

키워드

참고문헌 (42)

1. 두호경, "동의신계학", pp.1173~1178 (1993), 동양의학연구원
2. "2007년도 보건복지통계연보"[URL]
3. E Braunwald, "해리슨 내과학", pp.2178~ (2003), MIP
4. 朱震亨, "丹溪心法", pp.503~509 (1982), 대성문화사
5. 공정현, "만병회춘", pp.201~ (1980), 인민위생출판사
6. 林偑琴, "類證治裁", pp.77~ (1985), 族風文化社
7. 許浚, "標點•索引 東醫寶鑑. 東醫文獻硏究室再編輯", pp.337~ (2005), 法仁文化社
8. 심범상, "淸離滋坎湯에 의한 면역기능 연구", 동의생리병리학회지, 15(5), pp.693~696 (2001), 대한동의병리학회
9. 조경삼, "複合 韓藥劑 淸籬滋坎湯의 抗癌效果 및 作用機轉 糾明", 경희대학교 동서의학연구소 국제학술대회 논문집, pp.231~243 (1999)
10. Institute of Laboratory Animal Resources (Commission on Life Sciences, National Research Council, USA), "Guide for the care and use of laboratory animals", pp.1~118 (1996), National Academic press
11. Kavutcu M, "Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C", Nephron, 72, pp.269~274 (1996)
12. Lowry OH, "Protein measurement with the Folin phenol reagent", J Biol Chem., 193, pp.265~275 (1951)
13. Draper HH, "Methods in Enzymology", pp.421~ (1999), Academic Press
14. Eyer P, "Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent", Anal Biochem, 153, pp.57~66 (1986)
15. Quine SD, "Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in STZ-induced diabetic liver, kidney and heart", Pharmacol Rep, 57, pp.610~615 (2005)
16. Wellington K, "Silymarin: a review of its clinical properties in the management of hepatic disorders", BioDrugs, 15, pp.465~489 (2001)
17. Lorenz D, "Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications", Methods Find Exp Clin Pharmacol., 3, pp.103~106 (1981)
18. Velussi M, "Long-term(12 months) treatment with an anti-oxidant drug(silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients", J Hepatol, 26, pp.871~879 (1997)
19. Saller R, "The use of silymarin in the treatment of liver diseases", Drugs, 61, pp.2035~2063 (2001)
20. Lirussi F, "Silybin -beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent", Diabetes Nutr Metab, 15, pp.222~231 (2002)
21. Huseini HF, "efficacy of Silybum marianum(L.) Gaertn. (silymarin) in the treatment of type Ⅱ diabetes: a randomized, double-blind, placebo-controlled, clinical trial", Phytother Res., 20, pp.1036~1039 (2006)
22. Guerrero-Analco JA, "Antihyperglycemic effect of constituents from Hintonia standleyana in STZ-induced diabetic rats", Planta Med, 71, pp.1099~1105 (2005)
23. Uchiyama S, "Oral administration of beta-cryptoxanthin prevents bone loss in STZ-diabetic rats in vivo", Biol Pharm Bull, 28, pp.1766~1769 (2005)
24. Cohen MP, "Prevention of decline in renal function in the diabetic db", db mouse, 1996, pp.39, 270~274
25. Trachtman H, "Chronic diabetic nephropathy: role of inducible nitric oxide synthase", Pediatr Nephrol, 17, pp.20~29 (2002)
26. Pedro Montilla, "Red Wine Prevents Brain Oxidative Stress and Nephropathy inStreptozotocin-induced Diabetic Rats", BMB reports, 38(5), pp.539~544 (2005), 한국생화학분자생물학회
27. Sato S, "Protective effect of polyphenol- containing azuki bean(Vigna angularis) seed coats on the renal cortex in STZ-induced diabetic rats", J Nutr Biochem., 16, pp.547~553 (2005)
28. Sodikoff CH, "Laboratory profiles of small animal diseases. A guide to laboratory diagnosis", pp.1~36 (1995), St. Louise
29. Imaeda A, "Antioxidative effects of fluvastatin and its metabolites against DNA damage in STZ- treated mice", Food Chem Toxicol, 40, pp.1415~1422 (2002)
30. Clark TA, "Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in STZ-induced diabetic rats", Metabolism, 53, pp.1145~1151 (2004)
31. Ducobu J, "Dyslipidaemia and diabetes mellitus", Rev Med Liege, 60, pp.578~585 (2005)
32. Bhandari U, "Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats", J Ethnopharmacol, 97, pp.227~230 (2005)
33. Milionis HJ, "Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia", Am Heart J., 148, pp.635~640 (2004)
34. Forrester JS, "Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians", Circulation, 111, pp.1847~1854 (2005)
35. Kamada T, "Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients", Dig Liver Dis, 37, pp.39~43 (2005)
36. Cheng JW, "Rosuvastatin in the management of hyperlipidemia", Clin Ther, 26, pp.1368~1387 (2004)
37. Pirat B, "The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels", Anadolu Kardiyol Derg., 4, pp.318~322 (2004)
38. Zdrenghea D, "The effect of simvastatin associated with ranitidine and alcohol upon serum lipids", Rom J Intern Med, 42, pp.143~148 (2004)
39. Garg MC, "Effect of vitamin C supplementation on oxidative stress in experimental diabetes", Indian J Exp Biol, 35, pp.264~266 (1997)
40. Collier A, "Free radical activity in type 2 diabetes", Diabet Med., 7, pp.27~30 (1990)
41. Ceriello A, "New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications", Diabet Med, 9, pp.297~299 (1992)
42. Giugliano D, "Oxidative stress and diabetic vascular complications", Diabetes Care., 19, pp.257~267 (1996)

관련 논문AI추천